Philips Healthcare

1010 Murry Ridge Lane

Murrysville, PA, 15668 USA
Home Healthcare Solutions

Subject: Airline Travel with the Respironics Trilogy 100 and Trilogy 200

Date: 2 September 2011

To whom it may concern:

The Philips Respironics Trilogy 100 and Trilogy 200 identified in the table below are in compliance with commercial
airline EMI/RFI requirements.

Respironics has designed and tested the identified devices for compliance with section 21, Category M, RTCA DO-
160F EMI/RFI requirements as specified in the Code of Federal Regulations 14 CFR 382 “Nondiscrimination on the
Basis of Disability in Air Travel; Final Rule” and FAA Advisory circular AC No: 91-21B.

Respironics devices approved for airline use have airline use operating instructions included in the User Manual and
the following symbol on the device label that may be located on the bottom of the device:

The devices identified in the Tables below have been tested and comply with section 21, Category M, RTCA DO-
160F EMI/RFI requirements:

Tel:
Fax:

www.philips.com/Respironics
Trilogy 100 Ventilator, USA 1054260
Trilogy 100 Ventilator, Canada CA1054096
Trilogy 100 Ventilator, Latin America LA1054096
Trilogy 100 Ventilator, Australia AU1054096
Trilogy 100 Ventilator, Japan 1054655
Trilogy 100 Ventilator, Germany 1054097
Trilogy 100 Ventilator, International 1054096

Trilogy 200 Ventilator, USA 1040005

Trilogy 200 Ventilator, Canada CA1032800
Trilogy 200 Ventilator, Latin America LA1032800
Trilogy 200 Ventilator, Australia AU1032800
Trilogy 200 Ventilator, Japan 1032804
Trilogy 200 Ventilator, Germany 1032802
Trilogy 200 Ventilator, International 1032800

Please contact me if you have any questions or require additional information.

Sincerely,

Anthony Ciccarello
Senior Regulatory Manager, Sustainability and Standards

Tel:
Fax:

www.philips.com/Respironics